[Mechanism of NUF2 in Promoting NSCLC Progression through the Regulation of Ferroptosis].
- 1College of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030001, China.
- 2College of Basic Medical Sciences, Shanxi University of Medicine, Fenyang 032200, China.
- 3Fenyang Hospital of Shanxi, Fenyang 032200, China.
Abstract
Background
NUF2 component of NDC80 kinetochore complex (NUF2) is a core regulatory protein that ensures proper chromosome segregation, and its aberrant expression is closely associated with cancer initiation and progression. Although the expression level of NUF2 is higher in non-small cell lung cancer (NSCLC) than in normal tissues, its mechanism of action in NSCLC remains unclear. This study aims to investigate the mechanism by which NUF2 promotes the proliferation, migration, and invasion of NSCLC.Methods
The expression differences of NUF2 between NSCLC and normal lung tissues as well as the correlation between NUF2 expression and overall survival (OS) of NSCLC patients were analyzed via the Gene Expression Profiling Interactive Analysis (GEPIA) database. Immunohistochemical (IHC) staining was performed to detect the positive expression rate of NUF2 in NSCLC specimens. NUF2 knockdown and overexpression stable cell lines were established in the A549 cell line, and transfection efficiency was verified by Western blot (WB) and quantitative real-time polymerase chain reaction (RT-qPCR). The proliferation, migration, and invasion of transfected cells were assessed using the cell counting kit-8 (CCK-8), colony formation assay, wound healing assay, and Transwell assay. The expression levels of ferroptosis-related proteins were determined using WB and RT-qPCR. Commercial assay kits were utilized to measure the contents of malondialdehyde (MDA), reactive oxygen species (ROS), ferrous ion (Fe²+) and glutathione (GSH), while intracellular mitochondrial structural alterations were visualized by transmission electron microscopy (TEM). Xenograft tumor models were established. The expression levels of NUF2, SLC7A11 and ACSL4 were detected by WB, RT‑qPCR and IHC.Results
GEPIA analysis revealed that NUF2 was significantly highly expressed in NSCLC (P<0.05) and was associated with OS (P<0.001). Clinical statistical analyses demonstrated that upregulated NUF2 was significantly associated with advanced clinical stage (P<0.05) and lymph node metastasis (P<0.01). NUF2 knockdown markedly suppressed the proliferation, migration and invasion of NSCLC cells (P<0.001) and reduced xenograft tumor volume in vivo (P<0.05). Mechanistically, NUF2 silencing downregulated the expression of the ferroptosis master regulator SLC7A11 (P<0.01) while upregulating ACSL4 (P<0.01). The levels of MDA (P<0.01), ROS and Fe²+ (P<0.001) were all elevated following NUF2 knockdown, while the content of GSH decreased (P<0.001). TEM observation revealed that NUF2 knockdown led to mitochondrial shrinkage, reduced cristae number and increased membrane density. Conversely, NUF2 overexpression enhanced NSCLC cell proliferation, migration and invasion (P<0.001) and increased xenograft tumor volume (P<0.001). Meanwhile, SLC7A11 expression was elevated (P<0.01) and ACSL4 expression was decreased (P<0.01). The levels of ROS (P<0.001), MDA and Fe²+ were decreased (P<0.01), and the GSH level was increased (P<0.01).Conclusions
NUF2 is highly expressed in NSCLC and is closely associated with poor prognosis and lymph node metastasis. NUF2 inhibits ferroptosis by upregulating SLC7A11 expression and downregulating ACSL4 expression, thereby promoting the proliferation, migration, and invasion of NSCLC.
Related
- CDCA5 promotes hepatocellular carcinoma progression by suppressing ferroptosis through PP2Ac/p53/STEAP3 signaling
- Lnc-TIM3 promotes acute lymphoblastic leukemia progression through miR-5094-mediated regulation of TIM3
- TPX2 promotes osteosarcoma progression by conferring ferroptosis resistance through the AURKA/NRF2 signaling axis
- The Spliceosome Scaffold Component BCAS2 Promotes Pancreatic Cancer Progression through Weak 5 Splice Site Dependent Splicing Regulation
- Loss of Ferroptosis-suppressors Accelerates Breast Cancer Recurrence by Promoting Dormancy Exit
BibTeX
@article{liu2026mechanism,
title = {{[Mechanism of NUF2 in Promoting NSCLC Progression through the Regulation of Ferroptosis].}},
author = {Yani Liu and Jiaxuan Ren and Ruibin Zhao and Xiaoru Ma and Yunbo Di and Yirong Xu and Zhenwen Chen},
journal = {Zhongguo fei ai za zhi = Chinese journal of lung cancer},
year = {2026},
month = aug,
doi = {10.3779/j.issn.1009-3419.2026.106.23},
url = {https://europepmc.org/article/MED/42896969},
note = {CC BY},
}
RIS
TY - JOUR
TI - [Mechanism of NUF2 in Promoting NSCLC Progression through the Regulation of Ferroptosis].
AU - Yani Liu
AU - Jiaxuan Ren
AU - Ruibin Zhao
AU - Xiaoru Ma
AU - Yunbo Di
AU - Yirong Xu
AU - Zhenwen Chen
PY - 2026
DA - 2026/08/01
JO - Zhongguo fei ai za zhi = Chinese journal of lung cancer
DO - 10.3779/j.issn.1009-3419.2026.106.23
UR - https://europepmc.org/article/MED/42896969
AB - Background NUF2 component of NDC80 kinetochore complex (NUF2) is a core regulatory protein that ensures proper chromosome segregation, and its aberrant expression is closely associated with cancer initiation and progression. Although the expression level of NUF2 is higher in non-small cell lung cancer (NSCLC) than in normal tissues, its mechanism of action in NSCLC remains unclear. This study aims to investigate the mechanism by which NUF2 promotes the proliferation, migration, and invasion of NSCLC.Methods The expression differences of NUF2 between NSCLC and normal lung tissues as well as the correlation between NUF2 expression and overall survival (OS) of NSCLC patients were analyzed via the Gene Expression Profiling Interactive Analysis (GEPIA) database. Immunohistochemical (IHC) staining was performed to detect the positive expression rate of NUF2 in NSCLC specimens. NUF2 knockdown and overexpression stable cell lines were established in the A549 cell line, and transfection efficiency was verified by Western blot (WB) and quantitative real-time polymerase chain reaction (RT-qPCR). The proliferation, migration, and invasion of transfected cells were assessed using the cell counting kit-8 (CCK-8), colony formation assay, wound healing assay, and Transwell assay. The expression levels of ferroptosis-related proteins were determined using WB and RT-qPCR. Commercial assay kits were utilized to measure the contents of malondialdehyde (MDA), reactive oxygen species (ROS), ferrous ion (Fe²+) and glutathione (GSH), while intracellular mitochondrial structural alterations were visualized by transmission electron microscopy (TEM). Xenograft tumor models were established. The expression levels of NUF2, SLC7A11 and ACSL4 were detected by WB, RT‑qPCR and IHC.Results GEPIA analysis revealed that NUF2 was significantly highly expressed in NSCLC (P<0.05) and was associated with OS (P<0.001). Clinical statistical analyses demonstrated that upregulated NUF2 was significantly associated with advanced clinical stage (P<0.05) and lymph node metastasis (P<0.01). NUF2 knockdown markedly suppressed the proliferation, migration and invasion of NSCLC cells (P<0.001) and reduced xenograft tumor volume in vivo (P<0.05). Mechanistically, NUF2 silencing downregulated the expression of the ferroptosis master regulator SLC7A11 (P<0.01) while upregulating ACSL4 (P<0.01). The levels of MDA (P<0.01), ROS and Fe²+ (P<0.001) were all elevated following NUF2 knockdown, while the content of GSH decreased (P<0.001). TEM observation revealed that NUF2 knockdown led to mitochondrial shrinkage, reduced cristae number and increased membrane density. Conversely, NUF2 overexpression enhanced NSCLC cell proliferation, migration and invasion (P<0.001) and increased xenograft tumor volume (P<0.001). Meanwhile, SLC7A11 expression was elevated (P<0.01) and ACSL4 expression was decreased (P<0.01). The levels of ROS (P<0.001), MDA and Fe²+ were decreased (P<0.01), and the GSH level was increased (P<0.01).Conclusions NUF2 is highly expressed in NSCLC and is closely associated with poor prognosis and lymph node metastasis. NUF2 inhibits ferroptosis by upregulating SLC7A11 expression and downregulating ACSL4 expression, thereby promoting the proliferation, migration, and invasion of NSCLC.
SN - 1009-3419
SN - 1999-6187
ER -